RE:RE:RE:RE:How many big pharmas and what are they buyingI agree SB that the longer it goes, the less likely a PP. I've been thinking about it from the point-of-view of a potential JV partner. IMO the only way TLT gets a great deal before FDA approval for BTD/AA on NMIBC is to include either GBM or NSCLC in the mix, both of which should be getting close to a Ph1 trial application. Under a NDA, a bigPharma potential partner might be shown the lab results to date on GBM and NSCLC which shouild motivate them to entering a 'fair' deal. Pure speculation JMHO